MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
6.77
-0.57 (-7.71%)
Mar 31, 2025, 1:26 PM EDT - Market open
MeiraGTx Holdings Employees
As of December 31, 2024, MeiraGTx Holdings had 381 total employees, including 375 full-time and 6 part-time employees. The number of employees decreased by 44 or -10.35% compared to the previous year.
Employees
381
Change (1Y)
-44
Growth (1Y)
-10.35%
Revenue / Employee
$87,346
Profits / Employee
-$387,903
Market Cap
533.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MGTX News
- 6 days ago - MeiraGTx Holdings: Gaining Regulatory Focus - Seeking Alpha
- 18 days ago - MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars - Benzinga
- 18 days ago - MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - GlobeNewsWire
- 18 days ago - MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson's Disease and Industrialize MeiraGTx's Proprietary Manufacturing Process - GlobeNewsWire
- 5 weeks ago - MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy - GlobeNewsWire
- 2 months ago - MeiraGTx: 2 Possible Near-Term BLA Filings Could Ignite Shareholder Value - Seeking Alpha
- 2 months ago - MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations - GlobeNewsWire
- 4 months ago - MeiraGTx Holdings: Behind The Recent Rally - Seeking Alpha